Maryland State Retirement & Pension System’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-3,033
Closed -$107K – 1558
2024
Q1
$107K Hold
3,033
– – ﹤0.01% 1525
2023
Q4
$205K Hold
3,033
– – ﹤0.01% 1517
2023
Q3
$220K Hold
3,033
– – 0.01% 1467
2023
Q2
$226K Buy
3,033
+1,454
+92% +$86.1K ﹤0.01% 1488
2023
Q1
$84K Hold
1,579
– – ﹤0.01% 1512
2022
Q4
$107K Buy
+1,579
New +$145K ﹤0.01% 1498
2022
Q3
– Sell
-1,579
Closed -$150K – 536
2022
Q2
$150K Buy
+1,579
New +$193K ﹤0.01% 1467

Other funds holding DNA

Maryland State Retirement & Pension System's DNA Position: Q2 2024 in Review

Maryland State Retirement & Pension System sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 3,033 shares — an estimated $107K sold.

Maryland State Retirement & Pension System first reported a position in DNA in Q2 2022 and held it in 7 quarters. The position peaked at $226K in Q2 2023. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Maryland State Retirement & Pension System reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 3,033 Ginkgo Bioworks shares in Q2 2024, an estimated $107K.
  • Maryland State Retirement & Pension System first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 7 quarters.
  • Maryland State Retirement & Pension System's Ginkgo Bioworks position peaked at $226K in Q2 2023.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2024, filed 30 Jul 2024.